Connect with us

Health & Fitness

TNF Inhibitors for IBD May Open Door to SARS-CoV-2

(MedPage Today) — The tumor necrosis factor (TNF) inhibitor infliximab (Remicade) was associated with attenuated serological responses to SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD), a multicenter study from the U.K…

Published

on

TNF Inhibitors for IBD May Open Door to SARS-CoV-2